We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Medtronic PLC | NYSE:MDT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.58 | 0.72% | 81.50 | 81.92 | 81.01 | 81.07 | 4,986,496 | 01:00:00 |
From May 2021 to May 2024
By Robb M. Stewart
Medtronic PLC said Wednesday it has begun a pediatric clinical trial of its spinal tether for the treatment of scoliosis.
The medical-technology company said it enrolled its first patient and completed the first surgical procedure in its Braive IDE study, which will evaluate the safety and effectiveness of the growth modulation system for treatment of progressive adolescent idiopathic scoliosis.
The first patient was recruited by the Newcastle Upon Tyne Hospitals NHS Foundation Trust in England. The device is Medtronic's latest in the pediatric spine category, and the study's initiation reaffirms the company's commitment to continued innovation for pediatric patients, it said.
In morning trading, Medtronics shares were up 1% at $129.09, for a gain of 10% since the end of last year.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
September 22, 2021 10:40 ET (14:40 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Medtronic Chart |
1 Month Medtronic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
